Cetera Advisor Networks LLC Curis Inc Transaction History

Cetera Advisor Networks LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 13, 2020	SELL	$0.95 - $1.42 $380 - $568	-400 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$0.63 - $1.7 $252 - $680	400 New	400 $0
Q4 2019 Feb 10, 2020	SELL	$1.36 - $2.44 $31,470 - $56,461	-23,140 Closed	0 $0
Q2 2019 Aug 12, 2019	BUY	$1.36 - $2.35 $31,470 - $54,379	23,140 New	23,140 $42,000

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $409M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.